Abstract:Berberine hydrochloride (BBR) is a natural product widely used in clinical medicine and animal production. It has a variety of antimicrobial effects, but its complex antimicrobial mechanism has not been clarified. This study aimed to discover the metabolic markers and gain a new perspective on the antibacterial mechanism of BBR. The effects of different inhibitory concentrations of BBR on the survival and growth of standard strain Staphylococcus aureus ATCC 25923 were analyzed by the bacteriostatic activity test. Differences in intracellular metabolites of S. aureus following 19 μg/ml BBR exposure for 1 h were investigated by combining non-targeted metabolomics techniques of gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS). The results showed that the minimum inhibitory concentration of BBR against S. aureus was 51 μg/ml. A total of 368 and 3,454 putative metabolites were identified by GC-MS and LC-MS analyses, respectively. Principal component analysis showed the separation of intracellular metabolite profiles between BBR-exposed samples and non-exposed controls. Pathway activity profiling analysis indicated a global inhibition of metabolisms by BBR exposure, while enhancement was also found in nucleic acid metabolism, amino sugar, and nucleotide sugar metabolism. Several metabolic markers were screened out mainly based on their variable importance of projection values. Two pyridine dicarboxylic acids were significantly downregulated, suggesting the reduction of stress resistance. The oxidized phospholipid (PHOOA-PE) was accumulated, while lipid antioxidant gamma-tocopherol was decreased, and farnesyl PP, the synthetic precursor of another antioxidant (staphyloxanthin), was decreased below the detection threshold. This evidence indicates that BBR reduced the antioxidant capacity of S. aureus . Accumulation of the precursors (UDP-GlcNAc, CDP-ribitol, and CDP-glycerol) and downregulation of the key metabolite D-Ala-D-Ala suggest the inhibition of cell wall synthesis, especially the peptidoglycan synthesis. Metabolites involved in the shikimate pathway (such as 3-dehydroshikimate) and downstream aromatic amino acid synthesis were disturbed. This study provides the first metabolomics information on the antibacterial mechanism of BBR against S. aureus . The key metabolic markers screened in this study suggest that the shikimate pathway, staphyloxanthin synthesis, and peptidoglycan biosynthesis are new directions for further study of BBR antibacterial mechanism in the future.

Berberine Degradation Characteristics and its Degradation Pathway by a Newly Isolated Berberine-Utilizing Agrobacterium

Tetrahydroisoquinoline N-methyltransferase from Methylotenera Is an Essential Enzyme for the Biodegradation of Berberine in Soil Water

Evaluation of berberine as a natural fungicide: biodegradation and antimicrobial mechanism

Isolation And Characterization Of A Bacterial Strain Capable Of Efficient Berberine Degradation

Isolation and Characterization of Pseudomonas Sp. CBW Capable of Degrading Carbendazim

The Dynamic Shift of Bacterial Communities in Hybrid Anaerobic Baffled Reactor (ABR)—Aerobic Granules Process for Berberine Pharmaceutical Wastewater Treatment

Characterization of a Novel Cyfluthrin-Degrading Bacterial Strain Brevibacterium Aureum and Its Biochemical Degradation Pathway.

A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureus Revealed by Untargeted Metabolomic Studies

Isolation, Characterization and Phylogenetic Analysis of an Aerobic Bacterium Capable of Degrading Bensulfuronmethyl

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine

Degradation of the Novel Herbicide ZJ0273 by Amycolatopsis Sp. M3-1 Isolated from Soil

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota

Responses of human gut microbiota abundance and amino acid metabolism in vitro to berberine

Design, synthesis and antimicrobial activity of novel berberine derivatives

Transforming berberine into its intestine-absorbable form by the gut microbiota

Isolation of a 3-hydroxypyridine degrading bacterium, Agrobacterium sp. DW-1, and its proposed degradation pathway

Mechanism of β-cypermethrin metabolism by Bacillus cereus GW-01

[Berberine Action Targets and Its Absorption Behavior：how to Use Old Drug for New Mechanisms].

Berberine influences multiple diseases by modifying gut microbiota

Berberine Effect of Anti-microbiota-Possibility and Clinical Significance on Gut Microbiota and Metabolism: A Review

Therapeutic Effect of Berberine on Chronic Atrophic Gastritis Based on Plasma and Urine Metabolisms